199 related articles for article (PubMed ID: 17682447)
1. [Clinicopathological study of prostate cancer patients who had a serum PSA level of more than 20 ng/ml and were treated by a radical prostatectomy].
Udo K; Otsubo S; Sakamoto N; Iguchi A
Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):685-90. PubMed ID: 17682447
[TBL] [Abstract][Full Text] [Related]
2. Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy.
Onder AU; Yaycioglu O; Ataus S; Gul U; Demirkesen O; Yalcin V; Solok V
Int J Urol; 2003 Jun; 10(6):302-6; discussion 307-8. PubMed ID: 12757598
[TBL] [Abstract][Full Text] [Related]
3. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
4. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
5. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels.
Lepor H; Wang B; Shapiro E
Urology; 1994 Aug; 44(2):199-205. PubMed ID: 7519380
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.
Stamey TA; Yemoto CM; McNeal JE; Sigal BM; Johnstone IM
J Urol; 2000 Apr; 163(4):1155-60. PubMed ID: 10737486
[TBL] [Abstract][Full Text] [Related]
7. [Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens].
Kanno H; Umemoto S; Izumi K; Hasumi H; Osada Y; Ohta J; Mikata K; Tuchiya F
Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):649-59. PubMed ID: 16768146
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological analysis of transition zone cancer of the prostate: the clinical significance of coexistent non-transition zone cancer foci].
Sakamoto N; Hasegawa Y; Kuroiwa K; Koga H; Kotoh S; Nakashima M; Naito S
Nihon Hinyokika Gakkai Zasshi; 1999 Aug; 90(8):718-23. PubMed ID: 10487048
[TBL] [Abstract][Full Text] [Related]
9. Transitional zone and anterior peripheral zone of the prostate. A correlation of small-volume cancer in the biopsy cores and high psa with positive anterior margins in radical prostatectomy specimens.
Mai KT; Moazin M; Morash C; Collins JP
Urol Int; 2001; 66(4):191-6. PubMed ID: 11385304
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
[TBL] [Abstract][Full Text] [Related]
11. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
12. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
13. Impact of transition zone biopsies in detection and evaluation of prostate cancer.
Onder AU; Yalcin V; Arar O; Yaycioglu O; Citci A; Solok V
Eur Urol; 1998; 33(6):542-8. PubMed ID: 9743695
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of prostate cancer originating from the transition zone.
King CR; Ferrari M; Brooks JD
Urol Oncol; 2009; 27(6):592-7. PubMed ID: 18799332
[TBL] [Abstract][Full Text] [Related]
15. Pathological findings of radical prostatectomy specimens in Japanese men diagnosed on single core positive prostate biopsy in eight with a Gleason score less than 4.
Miyake H; Ono Y; Park SJ; Hara I; Eto H
Int J Urol; 2003 Jul; 10(7):383-6. PubMed ID: 12823693
[TBL] [Abstract][Full Text] [Related]
16. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.
Noguchi M; Stamey TA; Neal JE; Yemoto CE
J Urol; 2000 Jun; 163(6):1751-5. PubMed ID: 10799175
[TBL] [Abstract][Full Text] [Related]
17. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Sakai I; Harada K; Hara I; Eto H; Miyake H
BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
[TBL] [Abstract][Full Text] [Related]
19. Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones.
Augustin H; Erbersdobler A; Graefen M; Fernandez S; Palisaar J; Huland H; Hammerer P
Prostate; 2003 Apr; 55(1):48-54. PubMed ID: 12640660
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.
Takamatsu K; Matsumoto K; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Shinojima T; Kikuchi E; Asanuma H; Oya M
Urol Oncol; 2019 Sep; 37(9):575.e19-575.e25. PubMed ID: 30967332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
